CLINICAL_TRIALS
trial_result
· 2012-02-13
Clinical Trial Update: An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP [Phase 3]
Summary
Open-label Phase 3 trial of romiplostim in adults with immune thrombocytopenia (ITP) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Idiopathic Thrombocytopenic Purpura, Thrombocytopenia | Phase 3 | Status: COMPLETED | Results posted: 2012-02-13